Table 2 Laboratory data before the initiation of IVIG treatment

White blood count (10⁹/L)

15.3 (11.8–19.3)

16.6 (13.0–21.0)

0.281

Haemoglobin (g/L)

110.3 ± 10.9

111.4 ± 10.1

0.482

Haematocrit (%)

0.33 (0.32–0.36)

0.33 (0.31–0.36)

0.365

Platelet count (10⁹/L)

393.7 ± 159.7

411.9 ± 159.9

0.447

Neutrophil count (10⁹/L)

10.4 ± 5.2

12.0 ± 4.9

0.027^*

C-reactive protein (mg/L)

76.0 (43.0–119.0)

88.0 (51.9–136.0)

0.141

Erythrocyte sedimentation rate (mm/h)

35.2 ± 13.9

37.5 ± 12.9

0.235

Alanine aminotransferase (U/L)

39.0 (20.0–93.0)

35.0 (18.5–65.0)

0.064

Aspartate aminotransferase (U/L)

33.0 (25.0–52.0)

27.0 (23.0–43.5)

0.029^*

Albumin (g/L)

36.9 ± 5.8

35.6 ± 5.2

0.107

Sodium (mmol/L)

135.7 ± 2.5

135.8 ± 2.4

0.728

Potassium (mmol/L)

4.37 ± 0.53

4.23 ± 0.57

0.098

Chloride (mmol/L)

101.7 ± 3.1

101.0 ± 2.9

0.125

Brain natriuretic peptide (pg/mL)

887 (395–2213)

656 (195.5–1865)

0.539